Interesting Images18F-FDG PET/CT Findings in a Patient With NeurosarcoidosisChen, Xueqi PhD, MD∗; Chen, Guoqian MD†; Fu, Zhanli MD∗; Li, Qian MD‡Author Information From the ∗Department of Nuclear Medicine, Peking University First Hospital, Beijing †Department of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China ‡Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA. Received for publication March 20, 2020; revision accepted April 4, 2020. Xueqi Chen and Guoqian Chen contribute equally to this case report. Conflicts of interest and sources of funding: none declared. Correspondence to: Zhanli Fu, MD, Department of Nuclear Medicine, Peking University First Hospital, No. 8, Xishiku St, West District, Beijing, 100034, China. E-mail: email@example.com. Clinical Nuclear Medicine: August 2020 - Volume 45 - Issue 8 - p 640-641 doi: 10.1097/RLU.0000000000003101 Buy Metrics Abstract A 58-year-old woman experienced 4 months of headache, fatigue, and depression, as well as 1 week of confusion and hallucinations. 18F-FDG PET/CT showed numerous hypermetabolic lesions in the pituitary gland and stalk, dura mater, glossopharyngeal nerve, and cauda equina, as well as in cervical and mediastinal lymph nodes. Surgical biopsy of the mediastinal lymph node confirmed the diagnosis of sarcoidosis. The follow-up 18F-FDG PET/CT, performed at the eighth month after the treatment of glucocorticoids and immunosuppressive agents, demonstrated complete remission of the previous hypermetabolic lesions. Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.